Nazwa produktu: |
wodór 4,5α-epoksydo-6α-hydroksy-3-metoksy-17-metylomorfinianu [R-(R*,R*)]-winian |
Synonimy |
Dwuwinian dihydrokodeiny [USP]; kodeina, dihydro-, winian (1:1); DF 118; winian kwasu dihydrokodeinowego; Dwuwinian dihydrokodeiny; 117857 NSC; Dwuwinian parakodeiny; Tuscodin; UNII-8LXS95BSA9; wodór 4,5alfa-epoksydo-6alfa-hydroksy-3-metoksy-17-metylomorfinianu (R-(R*,R*))-winian; kodeina, dihydro-, winian (1:1) (6CI,7CI); morfinan-6-alfa-ol, 4,5-alfa-epoksy-3-metoksy-17-metylo-winian (1:1); morfinan-6-ol, 4,5-epoksy-3-metoksy-17-metylo-, (5alfa,6alfa)-, (R-(R*,R*))-2,3-dihydroksybutanodioesan (1:1) (sól) (9CI); morfinan-6alfa-ol, 4,5alfa-epoksyd-3-metoksy-17-metylo-winian (1:1) (sól) (8CI); (5alfa,6alfa)-3-metoksy-17-metylo-4,5-epoksymorfinan-6-ol |
Angielska nazwa |
4,5α-epoxy-6α-hydroxy-3-methoxy-17-methylmorphinan hydrogen [R-(R*,R*)]-tartrate;Dihydrocodeine Bitartrate [USP]; Codeine, dihydro-, tartrate (1:1); DF 118; Dihydrocodeine acid tartrate; Dihydrocodeine bitartrate; NSC 117857; Paracodeine bitartrate; Tuscodin; UNII-8LXS95BSA9; 4,5alpha-Epoxy-6alpha-hydroxy-3-methoxy-17-methylmorphinan hydrogen (R-(R*,R*))-tartrate; Codeine, dihydro-, tartrate (1:1) (6CI,7CI); Morphinan-6-alpha-ol, 4,5-alpha-epoxy-3-methoxy-17-methyl-, tartrate (1:1); Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt) (9CI); Morphinan-6alpha-ol, 4,5alpha-epoxy-3-methoxy-17-methyl-, tartrate (1:1) (salt) (8CI); (5alpha,6alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-6-ol |
MF |
C26H35NO15 |
Masie cząsteczkowej |
601.5538 |
InChI |
InChI=1/C18H23NO3.2C4H6O6/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;2*5-1(3(7)8)2(6)4(9)10/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3;2*1-2,5-6H,(H,7,8)(H,9,10)/t11-,12+,13-,17-,18-;;/m0../s1 |
Nr CAS |
5965-13-9 |
EINECS |
227-747-7 |
Struktury molekularnej |
|
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|